Stangest OncoVet II: Product Profile

Stangest OncoVet II is a named branded product for Dogs and cats; manufacturer positioning must be kept separate from independent clinical evidence.

Oral powder in 120 g and 240 g packs with presentation-specific measuring spoons. Intended species: Dogs and cats.

Per 3 g as listed by the manufacturer: whey protein 2,000 mg; magnesium gluconate 100 mg; alpha-lipoic acid 10 mg; L-arginine 150 mg; L-proline 75 mg; L-lysine monohydrochloride 50 mg; sodium ascorbate 300 mg; niacinamide 200 mg; vitamin D3 300 IU; vitamin K3 3 mg; zinc amino-acid chelate 6 mg; and sunflower oil.

Stangest presents OncoVet II as a complementary food intended to reinforce nutritional status during oncological processes and treatments, with amino acids, vitamins, antioxidants, minerals, and whey protein. Manufacturer pathway language about immunity, extracellular matrix, detoxification, apoptosis, or angiogenesis is not a clinical efficacy finding.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

The official product page and manufacturer technical bulletins establish composition and proposed nutritional rationale. No controlled canine or feline oncology trial of the finished OncoVet II formula demonstrating a defined tumor or survival outcome was identified. Ingredient adequacy and safety also depend on the patient’s complete diet, organ function, treatment, and other supplements.

Review dairy/whey sensitivity, vitamin D and K exposure, zinc, magnesium, alpha-lipoic acid, glucose regulation, gastrointestinal tolerance, liver or kidney disease, coagulation, surgery, and duplicate vitamins or minerals. Vitamin K3 and concentrated nutrients warrant particular attention to the current label and local formulation. Do not combine nutritional products by adding ingredient totals casually.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer identifies OncoVet II as a complementary food/nutritional supplement, not a veterinary medicinal product. No EU veterinary-medicine authorization for cancer treatment was identified. Local label and feed rules govern market use.

Spain; European Union

Document the exact pack, scoop supplied, lot, current formula, start date, diet, and every other vitamin or mineral source. Monitor appetite, vomiting, diarrhea, stool, weight, hydration, skin signs, bruising, and treatment tolerance. Ask whether chemistry, electrolytes, blood counts, coagulation, or nutritional assessment should change for the individual plan.